Positive Progress Secures $51.5M too Revolutionize Autism Therapy with Relationship-Focused Approach
The landscape of autism care is undergoing a notable shift, and positive Development is leading the charge. This week, the McLean, Virginia-based company announced a triumphant $51.5 million Series C funding round, bringing their total funding to over $100 million. This investment isn’t just about growth; it’s about expanding access to a fundamentally different, and increasingly vital, approach to supporting children with autism and their families.
As a seasoned observer of the healthcare and neurodiversity spaces, I’ve seen firsthand the challenges families face navigating autism diagnoses and treatment options. The current system, while well-intentioned, frequently enough feels fragmented, expensive, and focused on symptom management rather than fostering genuine development. Positive Development’s model offers a compelling option.
Beyond Behavior Modification: The Power of Developmental Relationship-Based Intervention (DRBI)
For decades,Applied Behavior Analysis (ABA) has been the dominant therapy for autism. While ABA can be effective, it often comes with a hefty price tag – exceeding $50,000 per child annually – and significant waitlists. More importantly, many families and individuals on the spectrum are seeking approaches that prioritize a child’s inherent strengths and emotional well-being.
This is where Positive Development’s core beliefs, Developmental Relationship-Based Intervention (DRBI), shines. DRBI isn’t about changing behavior; it’s about nurturing a child’s natural development through the power of connection. As Positive Development explains on their website, DRBI focuses on coaching parents to engage in “gentle and warm exchanges” with their children, fostering meaningful interactions that build trust and facilitate communication, learning, emotional regulation, and problem-solving skills.
Think of it this way: ABA often focuses on what a child does, while DRBI focuses on who a child is and how to help them thrive within the context of loving relationships.This subtle but profound difference is at the heart of Positive Development’s success.
A Holistic,Family-Centered Approach
Positive Development doesn’t just offer therapy; they provide a comprehensive support system. Families gain access to:
A Dedicated Clinical Support Team: Providing expert guidance and personalized care planning.
Parent Support Sessions: Empowering parents with the tools and confidence to implement DRBI principles in everyday life.
Personalized Care Plans: Tailored to each child’s unique needs and strengths.
Flexible Service Delivery: Offering both in-home and in-center services for convenience and accessibility.
Insurance Coverage: Working with major insurers like Aetna and UnitedHealthcare to minimize financial barriers.This holistic approach recognizes that supporting a child with autism isn’t just about therapy sessions; it’s about empowering the entire family.Scaling Impact: Expansion Plans and Value-Based Care
The Series C funding,co-led by aMoon,B Capital,and Flare Capital Partners,will fuel significant expansion. Positive Development currently operates in California, Oklahoma, Texas, Maryland, New Jersey, Florida, and Illinois, and plans to triple services in existing locations while expanding into 5-10 new states over the next few years.
Though,expansion isn’t the only goal. CEO and co-founder Mike Suiters emphasizes a commitment to advancing technology and deepening partnerships with health plans and state Medicaid programs. This includes expanding value-based payment models, which incentivize positive outcomes and cost-effectiveness – a critical step towards making high-quality autism care accessible to more families.
“The market is crying out for alternatives that are clinically effective, cost effective, and scalable. We’re in a unique position to help solve this problem,” Suiters stated. And the investors agree. Dr. Tomer Berkovitz, Managing Partner at aMoon, highlighted Positive Development’s ability to “improve outcomes and reduce the total cost of care,” aligning with aMoon’s mission to transform healthcare.
Addressing a Growing Need
The need for innovative autism care solutions is more urgent than ever.The CDC reports that approximately one in 31 children in the U.S. is diagnosed with autism. This increasing prevalence underscores the importance of developing and scaling effective, accessible, and affordable treatment options.
Companies like Cortica, which also offers a comprehensive suite of autism services and recently raised $80 million, are also contributing to this evolving landscape. However, Positive Development’s focus on DRBI offers a distinct and compelling alternative to traditional approaches.
*Looking Ahead:
![$51.5M Funding Boosts Autism Therapy Expansion | [Company Name] $51.5M Funding Boosts Autism Therapy Expansion | [Company Name]](https://medcitynews.com/wp-content/uploads/sites/7/2017/04/GettyImages-637108448.jpg)









